Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
A Abdin, M Schulz, U Riemer, B Hadëri… - … heart failure, 2022 - Wiley Online Library
… Heart failure (HF) treatment has changed substantially over … Mortality and Morbidity in Heart
Failure) randomized controlled … efficacy and safety in clinical trials and daily clinical practice. …
Failure) randomized controlled … efficacy and safety in clinical trials and daily clinical practice. …
Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis
Aims We sought to conduct a meta‐analysis regarding the safety and efficacy of sodium‐glucose
co‐transporter 2 (SGLT2) inhibitors in patients with heart failure (HF). Methods and …
co‐transporter 2 (SGLT2) inhibitors in patients with heart failure (HF). Methods and …
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial
CM O'Connor, DJ Whellan, KL Lee, SJ Keteyian… - Jama, 2009 - jamanetwork.com
… young compared with the general population with heart failure and did not have heart
failure with preserved left ventricular function (or diastolic heart failure). The only measure of …
failure with preserved left ventricular function (or diastolic heart failure). The only measure of …
The efficacy and safety of sacubitril/valsartan in heart failure patients: a review
R Zhang, X Sun, Y Li, W He, H Zhu… - Journal of …, 2022 - journals.sagepub.com
Heart failure (HF) is one of the leading causes of morbidity and mortality worldwide.
Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor, has been approved for the …
Sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor, has been approved for the …
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study
L Tavazzi, K Swedberg, M Komajda, M Böhm… - International journal of …, 2013 - Elsevier
Background Heart failure (HF) and chronic obstructive pulmonary disease (COPD) frequently
coexist, with undefined prognostic and therapeutic implications. We investigated clinical …
coexist, with undefined prognostic and therapeutic implications. We investigated clinical …
Efficacy and safety of tolvaptan in patients hospitalized with acute heart failure
… and 72 h, worsening or persistent heart failure, over-diuresis, … heart failure was defined as
the need for rescue therapy due to persistent or worsening signs and symptoms of heart failure…
the need for rescue therapy due to persistent or worsening signs and symptoms of heart failure…
Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial
… worsening chronic heart failure with diabetes and/or chronic kidney disease. Eur J Heart Fail.
… or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart …
… or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart …
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF
S van Diepen, AS Hellkamp, MR Patel… - … : Heart Failure, 2013 - Am Heart Assoc
… We explore the safety and efficacy of rivaroxaban in patients with heart failure (HF). … In this
analysis, the primary efficacy and safety treatment effects were similar between patients with …
analysis, the primary efficacy and safety treatment effects were similar between patients with …
Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials
RK Wali, M Iyengar, GJ Beck, DM Chartyan… - … : Heart Failure, 2011 - Am Heart Assoc
… with concomitant heart failure and CKD is increasing. Hence, it is important to understand
whether current standard therapies have a similar degree of efficacy and safety profiles in HF …
whether current standard therapies have a similar degree of efficacy and safety profiles in HF …
Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis
G Savarese, RP Giugliano, GMC Rosano… - JACC: Heart Failure, 2016 - jacc.org
… the relative efficacy and safety of … the efficacy and safety of NOACs in patients with AF and
HF enrolled in all phase III NOACs clinical trials and to detect whether the efficacy and safety of …
HF enrolled in all phase III NOACs clinical trials and to detect whether the efficacy and safety of …
相关搜索
- heart failure efficacy and safety analysis
- severe heart failure efficacy of spironolactone
- heart failure efficacy of carvedilol
- heart failure sacubitril valsartan
- heart failure exercise training
- heart failure ejection fraction
- acute heart failure
- heart failure patients
- heart failure chronic obstructive pulmonary disease
- efficacy and safety of rivaroxaban
- heart failure systematic review
- heart failure sglt2 inhibitors
- heart failure randomized controlled trial
- heart failure hf action
- efficacy and safety of tolvaptan
- heart failure meta analysis